ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1533	National Cancer Institute	Html	en	Cancell/Cantron/Protocel (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of Cancell/Cantron/Protocel as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	peer-reviewed scientific journals 0.623029 NCI Tumor Cell 0.661367 cell lines 0.687144 human cells 0.635256 aerobic metabolism 0.794285 bacterium P. cryptocides. 0.62979 PDQ cancer information 0.88904 cancer development. 0.663979 vitro NCI-60 DTP 0.62954 somewhat different explanations 0.628856 Cancer Terms 0.627276 principal manufacturers 0.71541 certain damaging conditions 0.634012 Topical skin application 0.63342 substantial antitumor activity. 0.625666 cancer information summary 0.875855 breast cancer prevention 0.656117 Tumor Cell Line 0.74552 clinical drug research 0.64982 Cancell/Cantron/Protocel 0.841588 Investigational New Drug 0.649141 cancerous cells 0.717346 NCI’s PDQ 0.624803 NCI PDQ cancer 0.71862	residual aerobic metabolism 0.655098 NCI Dictionary 0.62162 unapproved new drug 0.650693 numerous animal experiments 0.621001 completely primitive state 0.63055 Therapies Editorial Board 0.638692 vivo situation 0.631095 excretion—an unlikely situation 0.620899 original manufacturer 0.721066 cancer cells 0.761265 damaged normal cells 0.711253 critical point 0.644689 reference citations 0.63628 idealized conditions Cancell/Cantron/Protocel 0.671023 adult-onset diabetes mellitus 0.639765 additional biochemical reactions 0.628258 cell line screen 0.841075 National Cancer Institute 0.793891 NCI human cancer 0.696144 normal cells 0.997775 chronic energy stress 0.639389 Human Tumor Cell 0.638074 cancer information summaries 0.702185 artificial media 0.635059	CLICK HERE
1586	National Cancer Institute	Html	en	Vaginal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of vaginal cancer.	cell vaginal cancer 0.360195 lymph node dissection 0.326781 body 0.312996 abnormal areas 0.281727 PDQ cancer information 0.334259 vaginal cancer 0.760063 clinical trial search 0.36299 clinical trials 0.668187 cancer information summary 0.310305 clinical trial 0.454575 squamous cell cancer 0.354582 Vaginal Cancer Treatment 0.308045 Pap test 0.272131 patients 0.293377 IVB vaginal cancer 0.318217 NCI PDQ cancer 0.278314 malignant tumor cells 0.275963 Treatment Option Overview 0.274359 lymph nodes 0.290946 radiation therapy 0.589716 General information 0.282628 general cancer information 0.271401 treatment 0.460915 abnormal cells 0.349727 wide local excision 0.321438	Recurrent vaginal cancer 0.337303 new cancer treatments 0.27048 NCI-supported cancer 0.305828 cancer cells 0.3346 vaginal intraepithelial neoplasia 0.296856 Cancer Information Service 0.272009 vaginal cancer spreads 0.334927 squamous cell 0.369952 stage ivb 0.271421 treatment clinical trials 0.293735 National Cancer Institute 0.348129 tumor cells 0.290691 new treatment 0.303739 cervix 0.280807 IVA vaginal cancer 0.291708 external radiation therapy 0.454541 cancer clinical trials 0.3729 cells 0.353506 stage 0.310322 cancer information summaries 0.270039 comprehensive cancer information 0.270279 internal radiation therapy 0.457186 Cervical Cancer Treatment 0.289689 cancer 0.911572	CLICK HERE
1691	National Cancer Institute	Html	en	Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®)–Health Professional Version	Calcium, green tea, lycopene, pomegranate, selenium, soy and vitamin E have been studied for prostate cancer prevention or treatment. Read about laboratory and human studies on various prostate supplements in this expert-reviewed summary.	atypical small acinar 0.591788 dietary lycopene 0.5816 local-stage prostate cancer 0.605358 prostate cancer cell 0.611618 prostate cancer survivors 0.597981 total prostate cancer 0.586726 occult prostate cancer 0.591218 lycopene serum concentration 0.581941 lycopene intake 0.604495 prostate cancer cells. 0.594787 serum lycopene 0.591044 hormone-refractory prostate cancer 0.585389 metastatic prostate cancer 0.596215 cancer prostate cells 0.587339 prostate cancer incidence 0.586787 prostate cancer cells 0.74273 prostate cancer risk 0.675977 prostate cancer patients 0.695715 serum lycopene concentrations 0.582255 prostate cancer aggressiveness 0.585035 prostate cancer progressi 0.584763 lycopene 0.683385 end-of-study prostate lycopene 0.623399 Prostate Cancer Prevention 0.597202 serum psa levels 0.589012	human prostate cancer 0.61272 plasma lycopene levels 0.594142 study 0.645275 androgen-independent prostate cancer 0.585034 prostate cancer development 0.59941 nonmetastatic prostate cancer 0.584711 -resistant prostate cancer 0.587482 high-grade prostate cancer 0.596056 Prostate CAncer Therapy 0.605352 prostate cancer mortality 0.5969 prostate cancer biomarkers 0.590502 prostate cancer cases 0.586568 prostate lycopene concentration 0.627986 green tea 0.644093 prostate cancer patients. 0.585445 lycopene blood levels 0.586499 prostate cancer 0.954937 prostate cancer. 0.620441 aggressive prostate cancer 0.587452 prostate cancer risk. 0.60813 prostate cancer progression 0.591862 prostate lycopene concentrations 0.629097 lycopene levels 0.595352 small acinar proliferation 0.592927	CLICK HERE
1770	National Cancer Institute	Html	es	Prurito (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del prurito (picazón en la piel) como complicación del cáncer o su tratamiento. Se consideran los abordajes de manejo y tratamiento del prurito.	haemodialysis patients 0.476654 Section XII 0.477073 Rubenstein E 0.559292 Sin embargo 0.803552 Scientific American Medicine 0.676981 categoría farmacológica medicamento 0.526417 Am Acad Dermatol 0.571569 Clin Res 0.479277 Wolff K 0.536775 Acad Dermatol Venereol 0.493209 Farber EM 0.55456 patients with atopic 0.550773 Cancer Nursing 0.471101 PDQ Prurito 0.665745 Dermatol Venereol Leprol 0.6251 with atopic dermatitis 0.566467 toxina botulínica 0.473345 reacciones cutáneas 0.538217 patients with 0.621762 chronic idiopathic 0.533598 Pain Symptom Manage 0.649291 neuropathic pruritus 0.513717 Scientific American 0.875762 Oncol Nurs Forum 0.782558 Malignant cutaneous tumors 0.546882	Dosis Comentarios Referencias 0.53479 General Medicine 0.52531 terminal cancer patient 0.535978 All Free Clear 0.515267 Dermatol Venereol 0.632286 farmacológica medicamento dosis 0.550466 Clinical aspects 0.477546 Medicamento Dosis Comentarios 0.541353 Acta Derm Venereol 0.979711 Eisen AZ 0.543793 New York 0.832579 patients receiving 0.483634 Yosipovitch G 0.516371 mg diarios comenzar 0.507465 Abel EA 0.553787 Enterostomal Ther 0.474722 sistema nervioso central 0.522009 pruritus relief with 0.489446 policitemia vera 0.673444 Dermatol Ther 0.602936 Fitzpatrick TB 0.546636 Federman DD 0.567864 Bernhard JD 0.556935 chronic pruritus 0.522206	CLICK HERE
1884	National Cancer Institute	Html	es	Tratamiento de las neoplasias de células plasmáticas (incluso mieloma múltiple) (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de las neoplasias de células plasmáticas (incluso mieloma múltiple).	mieloma múltiple grupo 0.317462 multicentre randomized study 0.314956 Rajkumar SV 0.360993 Durie BG 0.317277 Dispenzieri A 0.381536 primary plasma cell 0.32094 Lacy MQ 0.31455 extramedullary plasmacytoma 0.321972 light chain 0.421207 Myeloma Study Group 0.325182 versus deferred treatment 0.314362 plasma cell 0.333759 monoclonal gammopathies 0.324288 Radiat Oncol Biol 0.320101 multiple myeloma 0.968571 systemic amyloidosis 0.315374 stem cell transplantation 0.348134 International Myeloma Working 0.450729 células plasmáticas tipo 0.324338 proteína m 0.360491 Rosiñol L 0.316442 patients with 0.434191 patients with primary 0.318338 plasma cell leukemia 0.319942 UK Myeloma Forum 0.317407	células madre 0.338769 Myeloma Working Group 0.450073 International Blood 0.317358 primary systemic amyloidosis 0.314303 peripheral blood stem 0.321195 células plasmáticas oligosecretoras 0.325603 Therneau TM 0.332031 monoclonal gammopathy 0.501114 Dimopoulos MA 0.326344 Kumar SK 0.315489 lesiones óseas 0.347582 light chain amyloidosis 0.337292 International Staging System 0.324252 monoclonal sérica tipo 0.317411 Kyle RA 0.395277 Clin Oncol 0.474276 myeloma with 0.317498 Oncol Biol Phys 0.320425 mieloma múltiple estadio 0.31799 Nordic Myeloma Study 0.324636 with newly diagnosed 0.31487 células plasmáticas neoplasia 0.324857 mieloma múltiple igg 0.323238 patients with newly 0.318559	CLICK HERE
1906	National Cancer Institute	Html	es	Tratamiento de la leucemia linfocítica crónica (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfocítica crónica.	origen judío ruso 0.422021 siguientes procedimientos 0.424569 células madre 0.989491 estadio iv 0.439551 siguientes aspectos 0.415966 proteína llamada bcl2 0.417559 leucemia linfoblástica aguda 0.524325 hueso compacto 0.45509 neoplasias mieloides 0.413049 rayos x 0.41087 Chronic Lymphocytic Leukemia 0.453986 estadios i 0.422864 enlace drugs approved 0.452281 célula madre mieloide 0.477075 células mieloides 0.465027 células t 0.445647 células anormales.ampliar aspiración 0.467907 National Cancer Institute 0.4112 sexo masculino 0.412514 Instituto Nacional 0.418791	LLC mejora 0.413093 célula madre linfoide 0.435741 PDQ Tratamiento 0.432911 exploración tep 0.412807 siguientes problemas 0.415002 presente sección 0.408632 leucemia mielógena 0.445228 explorador tep 0.413444 tirosina cinasa 0.45926 Physician Data Query 0.439508 estadio iii 0.439039 linfocitos t 0.431485 laboratorio piezas 0.414056 Antecedentes familiares 0.410684 leucemia mieloide aguda 0.50943 célula madre 0.588281 células sanguíneas maduras 0.551856 gen igvh 0.469992 siguientes sumarios 0.426268 siguientes pruebas 0.415779	CLICK HERE
1928	National Cancer Institute	Html	es	Tratamiento de los tumores de células germinativas del ovario (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de células germinativas del ovario.	células cancerosas destruyéndolas 0.567328 siguientes procedimientos 0.5945 estadio iv 0.763261 ovarios causa efectos 0.720865 siguientes tipos 0.44103 rayos x 0.435181 estadio ic 0.701359 estadio ib 0.706097 estadio ia 0.703099 enlace drugs approved 0.444726 Fallopian Tube 0.427273 células reproductoras 0.578706 área anormal.ampliar examen 0.456393 peritoneal primario 0.43365 estadio iva 0.49879 National Cancer Institute 0.427112 Instituto Nacional 0.496637 estadio iiia 0.688436 PDQ Tratamiento 0.459552	ligera presión 0.438027 estadio iiic 0.681996 ganglios linfáticos detrás 0.589451 estadio iia 0.703376 células madres 0.693148 cortará pequeños trozos 0.469591 presente sección 0.423353 estadio iic 0.591971 Physician Data Query 0.497349 or primary peritoneal 0.449903 estadio iii 0.989912 Nuevas opciones 0.42339 siguientes situaciones 0.508188 histerectomía abdominal 0.832509 siguientes pruebas 0.525524 siguientes sumarios 0.47228 corto tiempo 0.424715 siguientes estadios 0.515179	CLICK HERE
1954	National Cancer Institute	Html	es	Tratamiento del mesotelioma maligno (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer del mesotelioma maligno.	siguientes procedimientos 0.614487 estadio iv 0.791187 Malignant Mesothelioma 0.549358 estadio ii 0.653957 estadios ia 0.559097 vía oral 0.54921 rayos x 0.916803 estadio ib 0.585037 enlace drugs approved 0.58335 estadio ia 0.583181 ondas sonoras 0.565775 líquido anormales.ampliar biopsia 0.679304 siguientes síntomas 0.602559 National Cancer Institute 0.545373 siguientes riesgos 0.53912	siguientes tratamientos 0.580411 quimioterapia intraperitoneal hipertérmica 0.640252 detalles minúsculos 0.572451 Instituto Nacional 0.580849 PDQ Tratamiento 0.591752 alta potencia 0.560897 presente sección 0.540992 partes distantes 0.551484 Physician Data Query 0.667975 siguientes sitios 0.687794 pequeña incisión 0.582002 ecografía ayuda 0.565218 cuerpo llamada ecograma 0.656058 siguientes pruebas 0.740981	CLICK HERE
2023	National Cancer Institute	Html	es	Prevención del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de mama y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Risk Assessment Tool 0.639814 enfermedad benigna 0.724402 voluntarios sanos 0.550874 siguientes afecciones 0.583572 posibles daños 0.559702 vía oral 0.551992 largo plazo 0.555083 carcinoma lobulillar situ 0.643038 National Cancer Institute 0.566999 vitamina a 0.552574 siguientes riesgos 0.550628 Instituto Nacional 0.618668 protección ayuda 0.699167	Physician Data Query 0.746401 Estados Unidos 0.579171 suficiente ejercicio 0.906195 siguientes características 0.59401 prevención revisa 0.554009 PDQ Prevención 0.599371 Menor exposición 0.569365 siguientes formas 0.705774 pequeñas llamadas lobulillos 0.645602 Mayor edad 0.567138 genes brca1 0.883252 conductos.ampliar anatomía 0.589939 siguientes sumarios 0.661886	CLICK HERE
3424	National Cancer Institute	Html	es	Informes de patología	Hoja informativa que describe el tipo de información que puede aparecer en un informe de patología, el cual contiene los resultados de la examinación visual y microscópica del tejido extirpado durante una biopsia o cirugía.	página del nci 0.749066 cromosoma filadelfia 0.760969 ¿Cuánto tiempo 0.803391 leucemia mielógena 0.766464 tipo southern 0.748591	Detecta fragmentos 0.751768 simple vista 0.960274 Instituto Nacional 0.833257 cuello uterino 0.83163	CLICK HERE